Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Suicide risk in placebo-controlled studies of major depression.

Storosum JG, van Zwieten BJ, van den Brink W, Gersons BP, Broekmans AW.

Am J Psychiatry. 2001 Aug;158(8):1271-5.

PMID:
11481162
3.

[Antidepressants do prevent suicide, at least pending something better...].

Courtet P, Olié É.

Bull Acad Natl Med. 2014 Apr-May;198(4-5):881-92. Review. French.

PMID:
26753413
4.

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G.

BMJ. 2009 Aug 11;339:b2880. doi: 10.1136/bmj.b2880. Review.

5.

Suicide prevention and serotonergic drugs.

Montgomery SA.

Int Clin Psychopharmacol. 1993 Nov;8 Suppl 2:83-5. Review.

PMID:
8201249
6.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
7.

Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.

Tollefson GD, Fawcett J, Winokur G, Beasley CM Jr, Potvin JH, Faries DE, Rampey AH Jr, Sayler ME.

Ann Clin Psychiatry. 1993 Dec;5(4):209-24. Review.

PMID:
8312978
8.

Efficacy in long-term treatment of depression.

Montgomery SA.

J Clin Psychiatry. 1996;57 Suppl 2:24-30. Review.

PMID:
8626360
9.

Pharmacotherapy of affectively ill suicidal patients.

Malone KM.

Psychiatr Clin North Am. 1997 Sep;20(3):613-24. Review.

PMID:
9323316
10.

[Antidepressants, depression and suicide].

Rihmer Z.

Neuropsychopharmacol Hung. 2013 Sep;15(3):157-64. Review. Hungarian.

11.

Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder.

Braun C, Bschor T, Franklin J, Baethge C.

Psychother Psychosom. 2016;85(3):171-9. doi: 10.1159/000442293. Epub 2016 Apr 5. Review.

PMID:
27043848
12.

Antidepressants and suicidal risk.

Müller-Oerlinghausen B, Berghöfer A.

J Clin Psychiatry. 1999;60 Suppl 2:94-9; discussion 111-6. Review.

13.

Lithium in unipolar depression and the prevention of suicide.

Coppen A.

J Clin Psychiatry. 2000;61 Suppl 9:52-6. Review.

14.

Suicide and antidepressants.

Montgomery SA.

Ann N Y Acad Sci. 1997 Dec 29;836:329-38. Review.

PMID:
9616807
15.

[Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control].

Broich K.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 May;48(5):541-7. Review. German.

PMID:
15887064
16.

The effect of pharmacotherapy on suicide rates in bipolar patients.

Rihmer Z, Gonda X.

CNS Neurosci Ther. 2012 Mar;18(3):238-42. doi: 10.1111/j.1755-5949.2011.00261.x. Epub 2011 Aug 1. Review.

PMID:
22070662
17.

Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable.

Even C, Siobud-Dorocant E, Dardennes RM.

Br J Psychiatry. 2000 Jul;177:47-51. Review.

18.

Placebos, drug effects, and study design: a clinician's guide.

Quitkin FM.

Am J Psychiatry. 1999 Jun;156(6):829-36. Review.

PMID:
10360119
19.

Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors.

Hawton K, Sutton L, Haw C, Sinclair J, Harriss L.

J Clin Psychiatry. 2005 Jun;66(6):693-704. Review.

PMID:
15960561
20.

Pharmacotherapy in the prevention of suicidal behavior.

Montgomery SA, Montgomery DB, Green M, Bullock T, Baldwin D.

J Clin Psychopharmacol. 1992 Apr;12(2 Suppl):27S-31S. Review.

PMID:
1349615

Supplemental Content

Support Center